E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro

Experimental Dermatology

Volumn 22, Issue 4, 2013, Pages 255-261

  Dallaglio, Katiuscia ^a   Marconi, Alessandra ^a   Truzzi, Francesca ^a   Lotti, Roberta ^a   Palazzo, Elisabetta ^a   Petrachi, Tiziana ^a   Saltari, Annalisa ^a   Coppini, Maurizio ^a   Pincelli, Carlo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

E FABP; Keratinocytes; Psoriasis; Skin; Subpopulations

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INVOLUCRIN; K 10; K 16; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; EPIDERMIS CELL; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS;

CELL DIFFERENTIATION; CELLS, CULTURED; FATTY ACID-BINDING PROTEINS; HUMANS; KERATIN-10; KERATINOCYTES; PROTEIN PRECURSORS; PSORIASIS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING;

EID: 84875676689     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12111     Document Type: Article

References (30)

1. Fuchs E. J Cell Biol 1990: 111: 2807-2814.
2. Schürer N Y. Contact Dermatitis 2002: 47: 199-205.
3. Siegenthaler G, Hotz R, Chatellard-Gruaz D et al. Biochem Biophys Res Commun 1993: 190: 482-487.
4. Siegenthaler G, Hotz R, Chatellard-Gruaz D et al. Biochem J 1994: 302: 363-371.
5. O'Shaughnessy R F, Seery J P, Celis J E et al. FEBS Lett 2000: 486: 149-154.
6. Kusakari Y, Ogawa E, Owada Y et al. Mol Cell Biochem 2006: 284: 183-8. Erratum in: Mol Cell Biochem. 2007: 299: 1-3.
7. Yamamoto N, Kaneko I, Motohashi K et al. Prostaglandins Leukot Essent Fatty Acids 2008: 79: 21-6.
8. Schug T T, Berry D C, Shaw N S et al. Cell 2007: 129: 723-733.
9. Chen N N, Li Y, Wu M L et al. Exp Dermatol 2012: 21: 13-8.
10. Zimmerman A W, Veerkamp J H. Cell Mol Life Sci 2002: 59: 1096-10116.
11. Michalik L, Wahli W. Biochim Biophys Acta 2007: 1771: 991-998.
12. Tan N S, Shaw N S, Vinckenbosch N et al. Mol Cell Biol 2002: 22: 5114-5127.
13. Li B, Reynolds J M, Stout R D et al. J Immunol 2009: 182: 7625-7633.
14. Liu J W, Almaguel F G, Bu L et al. J Neurochem 2008: 106: 2015-2029.
15. Ogawa E, Owada Y, Ikawa S et al. J Invest Dermatol 2011: 131: 604-612.
16. Karvonen S L, Korkiamäki T, Ylä-Outinen H et al. J Invest Dermatol 2000: 114: 693-700.
17. Pincelli C, Haake A R, Benassi L et al. J Invest Dermatol 1997: 109: 757-764.
18. Marconi A, Dallaglio K, Lotti R et al. Stem Cells 2007: 25: 149-155.
19. Tiberio R, Marconi A, Fila C et al. FEBS Lett 2002: 524: 139-144.
20. Chirico F, Fumelli C, Marconi A et al. Exp Dermatol 2007: 16: 429-436.
21. Leigh I M, Navsaria H, Purkis P E et al. Br J Dermatol 1995: 133: 501-511.
22. Nickoloff B J, Mitra R S, Elder J T et al. Br J Dermatol 1989: 121: 161-174.
23. Owada Y, Suzuki I, Noda T et al. Mol Cell Biochem 2002a: 239: 83-86.
24. Masouyé I, Saurat J H, Siegenthaler G. Dermatology 1996: 192: 208-213.
25. Owada Y, Takano H, Yamanaka H et al. J Invest Dermatol 2002b: 118: 430-5.
26. Takao J, Yudate T, Das A et al. Br J Dermatol 2003: 148: 680-8.
27. Romanowska M, Reilly L, Palmer C N et al. PLoS ONE 2010: 5: e9701.
28. Hagens G, Roulin K, Hotz R et al. Mol Cell Biochem 1999: 192: 123-128.
29. Grabe N, Neuber K. Bioinformatics 2007: 23: 1309-1312.
30. Barker C L, McHale M T, Gillies A K et al. J Invest Dermatol 2004: 123: 892-901.